Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers have?
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers has 172 citations in the OpenAlex counts ScholarIQ stores.
When was Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers published?
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers has 2010 year in the ScholarIQ index.
What is the open-access status of Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers?
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers has closed oa status in the ScholarIQ index.
What is the DOI of Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers?
The DOI for Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers is on the source record.
What is the PMID of Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers?
The PMID for Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers is on the source record.
What is the OpenAlex record for Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers?
The OpenAlex for Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers is on the source record.